Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Orthofix Medical (OFIX) Operating Expenses (2016 - 2025)

Orthofix Medical's Operating Expenses history spans 16 years, with the latest figure at $152.1 million for Q4 2025.

  • For the quarter ending Q4 2025, Operating Expenses fell 2.86% year-over-year to $152.1 million, compared with a TTM value of $620.2 million through Dec 2025, up 86.74%, and an annual FY2025 reading of $620.2 million, up 0.75% over the prior year.
  • Operating Expenses for Q4 2025 was $152.1 million at Orthofix Medical, down from $162.9 million in the prior quarter.
  • The five-year high for Operating Expenses was $440.2 million in Q4 2023, with the low at $9.5 million in Q3 2023.
  • Average Operating Expenses over 5 years is $99.0 million, with a median of $31.5 million recorded in 2021.
  • Year-over-year, Operating Expenses plummeted 69.46% in 2023 and then surged 1396.2% in 2025.
  • Tracing OFIX's Operating Expenses over 5 years: stood at $31.5 million in 2021, then skyrocketed by 748.86% to $267.4 million in 2022, then soared by 64.61% to $440.2 million in 2023, then tumbled by 64.43% to $156.6 million in 2024, then fell by 2.86% to $152.1 million in 2025.
  • Per Business Quant, the three most recent readings for OFIX's Operating Expenses are $152.1 million (Q4 2025), $162.9 million (Q3 2025), and $152.4 million (Q2 2025).